Vaginal Repair of Post Cesarean Istmocele
OWarda
Vaginal Repair of Symptomatic Postcesarean Isthmocele: Evaluating A Simple Novel Technique
1 other identifier
interventional
20
1 country
1
Brief Summary
20 WOMEN WITH SYMPTOMATIC POSTCESAREAN ISTHMOCELE (NICHE) WILL BE RECRUITED EVALUATED AND SUBJECTED TO A VAGINAL REPAIR OF THE DEFECT, RESULTS WILL BE ANALYZED.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2021
CompletedFirst Submitted
Initial submission to the registry
September 15, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2022
CompletedNovember 18, 2021
September 1, 2021
12 months
September 15, 2021
November 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
myometrial thickness in supracervical area
the myometrial thickness in the supracervical region is measured by transvaginal ultrasound postoperatively
at 1 month postoperative
Study Arms (1)
women with symptomatic post cesarean Istmocele
OTHERvaginal surgical repair of post cesarean symptomatic isthmocele using conventional low cost surgical techniques
Interventions
after preoperative identification of the borders of the isthmocele using transvaginal ultrasound measurements, the isthmocele is repaired via vaginal approach
Eligibility Criteria
You may qualify if:
- women diagnosed with symptomatic post cesarean isthmocele.
- should present with abnormal uterine bleeding .
You may not qualify if:
- presence of any other uterine pathology,
- presence of adnexal pathology,
- presence of malignancies,
- presence of pregnancy,
- presence of infection in the lower genital tract ,
- general cause of bleeding
- women not accepting the procedure,
- women not consented
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University Hospitals
Al Mansurah, Dakahlya Governorate, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2021
First Posted
November 18, 2021
Study Start
September 4, 2021
Primary Completion
August 20, 2022
Study Completion
December 20, 2022
Last Updated
November 18, 2021
Record last verified: 2021-09